These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7487309)

  • 1. [Treatment of chronic heart failure: current views].
    Komajda M
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):603-6. PubMed ID: 7487309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Digitalis and beta-blockers: what treatment, what dose and for which patient?].
    Bouhour JB
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():17-21. PubMed ID: 10830084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacotherapy of chronic heart failure].
    Hoppe UC
    Z Arztl Fortbild Qualitatssich; 2003 Apr; 97(2):113-9. PubMed ID: 12806816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with beta blockers in heart failure mortality trials.
    Eichhorn EJ
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V21-9. PubMed ID: 10526700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing readmissions for congestive heart failure.
    Hoyt RE; Bowling LS
    Am Fam Physician; 2001 Apr; 63(8):1593-8. PubMed ID: 11327436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ACE inhibitors, beta blockers, AT-1 antagonists in heart failure. Right dosage and combination].
    Fliri M
    MMW Fortschr Med; 2002 Nov; 144(48):38-43. PubMed ID: 12532542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is there an indication for the association of betablockers and angiotensin II receptor antagonists in cardiac failure?].
    Jondeau G; Milleron O; Morisson-Castagnet JF
    Arch Mal Coeur Vaiss; 2004 Jun; 97(6):641-6. PubMed ID: 15283038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the outcome in men and women with chronic heart failure.
    De Feo S; Opasich C
    Ital Heart J; 2003 Aug; 4(8):511-3. PubMed ID: 14564974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Revised insights and therapeutic goals in the treatment of chronic heart failure].
    van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(29):1507-11. PubMed ID: 10443272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors in left ventricular dysfunction.
    Linn WD
    Pharmacotherapy; 1996; 16(2 Pt 2):50S-58S. PubMed ID: 8668606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacologic treatment of chronic congestive heart failure].
    Halawa B
    Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibitors and beta blockers in chronic congestive cardiac failure: therapeutic basis.
    Manoria PC; Manoria P
    J Indian Med Assoc; 2003 May; 101(5):311-2, 315. PubMed ID: 14575221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
    Tsuyuki RT; Yusuf S; Rouleau JL; Maggioni AP; McKelvie RS; Wiecek EM; Wang Y; Pogue J; Teo KK; White M; Avezum A; Latini R; Held P; Lindgren E; Probstfield J
    Can J Cardiol; 1997 Dec; 13(12):1166-74. PubMed ID: 9444298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
    Krum H; Haas SJ; Eichhorn E; Ghali J; Gilbert E; Lechat P; Packer M; Roecker E; Verkenne P; Wedel H; Wikstrand J
    Eur Heart J; 2005 Oct; 26(20):2154-8. PubMed ID: 16014644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
    Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
    Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New therapeutic prospects in heart failure. ACE inhibitors and beta blockers].
    Capone A; Carfagna P; Paravati V; Bianco G; Battista M; Brandimarte C
    Recenti Prog Med; 1999 Mar; 90(3):136-42. PubMed ID: 10228352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic and clinical rationales for using beta-blockers in heart failure.
    Bristow MR
    J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.